Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Antti Luiro portrait

Antti Luiro

Head of Nordic ER Development, Analyst

Dækning

LeadDeskNightingale HealthLoihdeSpringvestAiforia TechnologiesQt Group

Seneste indhold

ViserAlle indholdstyper

Aiforia Extensive Report: Track open for market takeover

Omfattende analyse 24.04.2025, 22.33 af Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Potential for generous excess returns in Inderes recommendations

Artikel 11.04.2025, 17.10 af Antti Luiro

Faron secures sufficient financing until early 2026 with convertible bonds

Analytikerkommentar 04.04.2025, 07.57 af Antti Luiro
Faron Pharmaceuticals

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Aiforia's image recognition models also available on the PathPresenter platform

Analytikerkommentar 24.03.2025, 07.25 af Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Aiforia’s partnership with Techcyte offers an alternative to the structure of the market’s future value chain

Analytikerkommentar 21.03.2025, 12.50 af Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Aiforia’s partner network expands to Canada

Analytikerkommentar 18.03.2025, 09.45 af Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Nightingale OTC trading in the US likely to start already within a week

Analytikerkommentar 18.03.2025, 07.59 af Antti Luiro
Nightingale Health

Nightingale applies for its shares to be listed on the Main Market of Nasdaq Helsinki

Analytikerkommentar 13.03.2025, 07.16 af Antti Luiro
Nightingale Health

Aiforia H2'24: The fruits of customer wins are ripening

Analyse 10.03.2025, 12.04 af Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Nightingale H1'FY25: Blood draws again

Analyse 07.03.2025, 10.45 af Antti Luiro
Nightingale Health
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.